Dr. Kongkrapan Intarajang, CEO of GC, together with his executive team, present CoviClear, or the silver nanoparticle disinfection unit to help reduce the risk of COVID-19 transmission, and PPE, to Rajavithi Hospital
GC Group, led by Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented the silver nanoparticle disinfection unit CoviClear, which is designed to help lower the risk of COVID-19 transmission, along with raw materials to produce two types of disinfectant liquid: triethanolamine for which GC is the only manufacturer in Thailand, and pharmaceutical-grade glycerine for use in CoviClear, to Rajavithi Hospital. The donation was received by the hospital’s Director, Dr. Somkiat Lalitwongsa.
In addition, GC presented 500 3D printed face shields made from bioplastic, providing a biodegradable, strong and durable solution, and sterilized with alcohol 70% produced by GC Group’s volunteers, to Rajavithi Hospital.
CoviClear is an innovation developed by GC that increases the disinfection and prevention of germs by releasing silver nanoparticles through a micron-sized nozzle in the form of a vapor. The vapor pairs the silver nanoparticles with viruses, bacteria and other diseases which a person carries, including on their clothing, killing them on contact without causing any harm.